Travere Therapeutics Inc (TVTX)
19.00
-0.08
(-0.42%)
USD |
NASDAQ |
Jan 08, 16:00
18.99
-0.01
(-0.05%)
Pre-Market: 08:19
Travere Therapeutics Enterprise Value: 1.584B for Jan. 8, 2025
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Boston Scientific Corp | 150.04B |
| Perspective Therapeutics Inc | -27.57M |
| Electromed Inc | 249.35M |
| Xtant Medical Holdings Inc | 93.15M |
| Myomo Inc | 202.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -54.81M |
| Revenue (Quarterly) | 62.90M |
| Total Expenses (Quarterly) | 118.92M |
| EPS Diluted (Quarterly) | -0.70 |
| Gross Profit Margin (Quarterly) | 97.41% |
| Profit Margin (Quarterly) | -87.14% |
| Earnings Yield | -23.95% |
| Normalized Earnings Yield | -23.10 |